期刊文献+

血管内皮生长因子对原发性肝癌的预测分析 被引量:3

Study on Diagnostic Value of Vascular Endothelial Growth Factor for Primary Hepatocellur Carcinoma
下载PDF
导出
摘要 目的:探讨血管内皮生长因子(VEGF)对原发性肝细胞癌(PHC)临床诊断的价值。方法:选择21例PHC及36例肝硬化患者作为研究对象,采用酶联免疫吸附方法检测其血清VEGF表达水平,分析其与甲胎蛋白(AFP)的相关性及对PHC发生的判断价值。结果:PHC患者血清VEGF表达水平高于肝硬化患者,肝硬化患者高于健康对照组(Hc=19.672,P〈0.05);血清VEGF与AFP呈正相关(r2=0.488,P〈0.05);血清VEGF、AFP预测PHC发生的接受者操作特性曲线(ROC)为0.819和0.774,二者均能预测PHC发生(P〈0.05);以VEGF≥106.6 pg/mL和AFP≥30.06 ng/mL作为预测指标,ROC为0.76(495%,CI为0.633~0.866),其特异性达86.1%;以血清VEGF和AFP为参数,拟合预测PHC发生的Logistic二元回归方程,模型方程拟合优度高(χ2=6.097,P〈0.05),预测PHC发生的准确率达78.9%。结论:VEGF和AFP可用于预测PHC发生,如二者联合作为预测因素,其特异性和准确性均较高。 Objective: To study the clinical value of vascular endothelial growth factor(VEGF) for primary hepatocellur carcinoma(PHC). Methods: 21 patients with PHC, 36 patients with liver cirrhosis and 10 healthy controls were enrolled in the study. VEGF was detected by ELISA. The relationship between VEGF and AFP and their predicting value for the happening of PHC was analyzed. Results: The level of serum of VEGF in the patients with PHC was higher than that in liver cirrhosis, and that in liver cirrhosis was higher than that in healthy controls(He= 19.672,P〈0.05). The positive correlation was found between VEGF and AFP(r^2= 0.488,P〈0.05). The area under the ROC of VEGF, AFP predicting PHC was 0.819 and 0.774 respectively (all P〈 0.05). Combined VEGF≥ 106.6 pg/mL with AFP≥30.06 ng/mL as a parameter predicting PHC, the area under the ROC was 0.764(95%,CI: 0.633~0.866), the specificity was 86.1%, the logistic binary regression equation with VEGF and AFP had high goodness-of-fitting(χ^2=6.097, P〈0.05), and the accuracy was 78.9%.Conclusion: Both VEGF and AFP all could predict occurrence of PHC, and the combination of two. If taken as predictors together, they had very high specificity and accuracy.
出处 《抗感染药学》 2014年第4期355-358,共4页 Anti-infection Pharmacy
关键词 肝细胞癌 血管内皮生长因子 甲胎蛋白 primary hepatocellur carcinoma(PHC) VEGF, AFP
  • 相关文献

参考文献16

  • 1Kaseb AO, Morris JS, Hassan MM, et al. Clinical and prognostic implications of plasma insulin-like growth fac- tor- 1 and vascular endothelial growth factor in patients with hepatocellular carcinoma[J].,/ Clin 0ncoi,2011,29 (29):3892-3899.
  • 2吴孟超.原发性肝癌治疗的进展及展望[J].第二军医大学学报,2002,23(1):1-4. 被引量:82
  • 3Fantozzi A, Gruber DC, Pisarsky L, et al. VEGF-mediat- ed angiogenesis links EMT-induced cancer sternness to tu- mor initiation[J]. Cancer Res, 2014, 74(5): 1566-1575.
  • 4贾继东,李兰娟.慢性乙型肝炎防治指南(2010年版)[J].中华肝脏病杂志,2011,19(1):13-24. 被引量:3212
  • 5Bruix J, Sherman M. Management of hepatocellular carci- noma: an update[J]. Hepatology, 2011, 53(3): 1020-1022.
  • 6Beasley RP, Lin CC, Hwang LY, et al. Hepatocellular car- cinoma and hepatitis B virus:a prospective study of 22 707 men in Taiwan[J]. Lancet, 1981, 2(8256): 1129-1133.
  • 7Forner A, Reig M, Bruix J. Alpha-fetoprotein for hepato- cellular carcinoma diagnosis: the demise of a brilliant star [J]. Gastroenterology, 2009, 137(1): 26-29.
  • 8Senger DR, Galli S J, Dvorak AM, et al. Tumor cells se- crete a vascular permeability factor that promotes accu- mulation of ascites fluid[J]. Science, 1983, 219(4587): 983-598.
  • 9Chung AS, Lee J, Ferrara N. Targeting the tumour vascu- lature: insights from physiological angiogenesis[J].Nat Rev Cancer, 2010, 10(7): 505-514.
  • 10Ferrara N, Gerber HP, Couter JL. The biology of VEGF and its receptors[J]. Nat Med, 2003, 9(6): 669-676.

二级参考文献26

共引文献3291

同被引文献59

  • 1张伟,任凤云,金丹,潘艳明,胡静,冯玉宽.血管内皮生长因子-D表达与非小细胞肺癌淋巴管生成和淋巴结转移的相关性[J].中国老年学杂志,2014,34(11):2917-2920. 被引量:9
  • 2Feitelson MA. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellu- !ar ccar-cinoma [J]. Cancex Letters,2006,239( 1): 10-20.
  • 3Yamaguchi R,Yano H, Nakashima O,et al. Expression of vascular endothelial growth factor-C in human hepatocel- ular carcinoma [J]. Journal of Gastroenterology and Hepa-tology, 2006,21 (1 Pt 1):152-160.
  • 4Chen J,Torcia S,Xie F,et al. Somatic cells regulate ma- ternal mRNA translation and developmental competence ofimouse o0eytes [J]. Nat Cell Biol,2013,15 (12) : 1415- 1423.
  • 5Kubo H ;Fujiwara T, Jussila L, et al. Involvement of vas- cular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angio- genesis [J]. Blood, 2000,96(2) :546,553.
  • 6Stacker SA,Caesar C,Baldwin ME,et al. YEGF-D pro- motes the metastatic spread of tumor cells via the lym- phatics [J]. Nat Med,2001,7(2): 186-191.
  • 7Pech M,Mohnike: K, Wieners G, et al. Radiotherapy of liver metastases. Comparison of target volumes and dose- volume histograms employing CT- or MRI-based treat- merit planning [J].' Strahlentherapie und Onkologie : Organder Deutschen Rontgengesellschaft, 2008,184 (5) : 256- 261.
  • 8van Keimpema L,de Koning DB,Strijk SP,et al. Aspira- tion-sclerotherapy results in efftive control of liver vol- ume in patients with liver cysts [J]. Digestive Diseases and Sciences, 2008,53 (8) : 2251-2257.
  • 9Ferrara N,Gerber HP,LeCouter J. The biology of VEGF and its receptors [J]. Nat Med,2003,9(6):669-676.
  • 10Jehsch M,Kaipainen A,Joukov V,ct al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice [J]. Science, 1997,276(5317) : 1423-1425.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部